Home › Funds › Decheng Capital LLC › UPB
Decheng Capital LLC position in UPB
UPSTREAM BIO INC · Health Care
Decheng Capital LLC reported holding 2,724,868 shares of UPB (UPSTREAM BIO INC) in its Q3 2026 13F filing — a position valued at US$14.4M, representing 2.10% of its reported portfolio and ranking #5 among its reported holdings. Decheng Capital LLC has disclosed UPB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Decheng Capital LLC's UPB position evolved
Decheng Capital LLC first disclosed a stake in UPB in Q4 2024 at 3,285,293 shares (US$54.0M). The position peaked in Q4 2025 at 3,143,078 shares, worth US$85.3M. Across 8 filings, Decheng Capital LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 2,724,868 shares valued at US$14.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 3.29M | $54.01M | New |
| Q1 2025 | 3.29M | $20.11M | Hold |
| Q2 2025 | 3.29M | $36.07M | Hold |
| Q3 2025 | 3.29M | $61.80M | Hold |
| Q4 2025 | 3.14M | $85.33M | Reduce |
| Q1 2026 | 2.72M | $24.52M | Reduce |
| Q2 2026 | 2.72M | $18.86M | Hold |
| Q3 2026 | 2.72M | $14.36M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UPB and 13F data
UPB (UPSTREAM BIO INC) is a Health Care company. 46 other funds we track also report a position in UPB — the largest reported positions include ORBIMED ADVISORS LLC (US$39.4M), Enavate Sciences GP, LLC (US$17.0M), Parkman Healthcare Partners LLC (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UPB
- ORBIMED ADVISORS LLC 5.69M sh · $39.40M · Q2 2026
- Enavate Sciences GP, LLC 2.46M sh · $17.02M · Q2 2026
- Parkman Healthcare Partners LLC 935.25K sh · $6.47M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 600.95K sh · $4.16M · Q2 2026
- Samsara BioCapital, LLC 353.72K sh · $2.45M · Q2 2026
- Propel Bio Management, LLC 335.39K sh · $1.77M · Q3 2026
More on Decheng Capital LLC
FAQ
How long has Decheng Capital LLC held UPB?
Decheng Capital LLC has disclosed UPB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Decheng Capital LLC's current position in UPB?
As of Q3 2026, Decheng Capital LLC holds 2.72M shares of UPB (UPSTREAM BIO INC), valued at $14.36M, representing 2.10% of its reported portfolio and ranking #5.
Has Decheng Capital LLC been buying or selling UPB?
In the latest 13F filing (Q3 2026), Decheng Capital LLC held unchanged its position in UPB. The position peaked in Q4 2025 at 3.14M shares.
Which other funds hold UPB?
Other major institutional holders of UPB include ORBIMED ADVISORS LLC, Enavate Sciences GP, LLC, Parkman Healthcare Partners LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.